Brief: Idera Pharmaceuticals Q2 Loss Per Share $0.59
Aug 2 (Reuters) - Idera Pharmaceuticals Inc IDRA.O :
* IDERA PHARMACEUTICALS REPORTS SECOND QUARTER 2018
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q2 LOSS PER SHARE $0.59
* Q2 EARNINGS PER SHARE VIEW $-0.82 -- THOMSON REUTERS
I/B/E/S
Source text for Eikon: ID:nGNX65mxk7
Further company coverage: IDRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aceragen
See all newsBrief: Aceragen CEO John Taylor's Employment With Co Terminated
Brief: Aceragen Inc To Delist From The Nasdaq Stock Market
Aceragen Inc expected to post a loss of $1.20 a share - Earnings Preview
Brief: Aceragen Board Determined It Is In Best Interests Of Co,To Effect Transfer,Assignment Of All Of Co's Assets To Assignee
Aceragen Inc reports results for the quarter ended in March - Earnings Summary